A Randomized Trial of Levocarnitine Prophylaxis to Prevent Asparaginase-Associated Hepatotoxicity in Adolescents and Young Adults Receiving Acute Lymphoblastic Leukemia Therapy
-
Enrollment
This study is not currently enrolling. -
Associated Conditions
-
Research Area
Pediatrics Research -
Location
-
Principal Investigator
-
Sponsor
COG
The overall goal of this study is to determine whether adding levocarnitine to standard of care ALL treatment will reduce the chances of developing severe liver damage from asparaginase chemotherapy.